Ozenoxacin, a novel nonfluorinated quinolone for impetigo treatment: Its activity in resistant isolates involved in superficial skin infections

Background: Ozenoxacin (OZN), a novel nonfluorinated quinolone for the topical treatment of impetigo has shown to be effective against MRSA isolates.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research